The Leading Diabetes Digital Management Expert in the World

Sinocare, a high-tech company, has been taking advantage of biosensing technology to develop, produce, and sell various rapid diagnostic test products for chronic diseases for use by patients with chronic diseases and medical practitioners. We have been dedicating to providing innovative, high-quality products and services to people with diabetes and other chronic diseases to improve their quality of life.

Dreaming of "making every Chinese diabetic have a blood glucose meter", Sinocare was founded in Changsha, Hunan Province in 2002, and has started the journey to promote the maximum application of blood glucose monitoring and the diabetes prevention industry in China ever since.

In China, more than 50% of diabetics use Sinocare products for self-monitoring, which has helped the popularization of blood glucose meters and self-monitoring and management of blood glucose among diabetics in China.

Sinocare acquired Nipro Diagnostic Inc. (now renamed as Trividia Health Inc.) and PTS Diagnostics Inc. in 2016 and has been working on improving the quality of life of users around the world and providing fast, accurate, easy, and portable medical equipment and information management systems for patients with chronic diseases and medical practitioners.


China's first listed company of blood glucose meter


In the Chinese retail market

R&D centers

Production bases


World NO.4 BGMS company


Products sold to 135 countries


Over 25 million users worldwide


International certificates

Diabetes Digital Management

We are committed to developing a diabetes and related chronic disease digital management model that integrates "Biosensor Biosensing + S.oT IoT + Smart Healthcare + Guided Healthy Lifestyle," providing innovative and systematic smart healthcare solutions for the prevention and treatment of chronic diseases.

Patient Home 

Intra-hospital and Extra-hospital Care Integration
Online and Offline Integration